A Prospective French National Survey to Assess Renal Safety of Amphotericin B lipid Complex and Liposomal Amphotericin B

F. Saliba 1 *, N. Cheron 2, Ph. Ichai I, A. Renault 3, A. Sirvent 4, S. Depi[ s, B. Saulquin 6, B. Witz 7, S. Visanca a, O. Bastien 9, S. Guillaumin

Author address: 

1AP-HP, HOpital Paul Brousse, UniversitO Paris Sud, Villejui[, France, 2Centre medical Bligny, Briissous- Forges, France, 3HOpital Curule blanche, Brest, France, 4HOpital Archet, Nice, France, 5HOpital Huriez, Lille, France, 6HOpital HOtel Dieu

Abstract: 

Purpose: Lipid-based amphotericin B formulations (LF) have been recommended to treat patients suffering from renat insufficiency. We report a prospective mutticentre survey to assess renat function in adult patients treated for funga[ infections with LF: Abe[cet ® (ABLC) and AmBisome ® (C-Amb). Description: 88 patients (43 F, 45 M) with a mean age of 49.64-14 years were inctuded and evatuabte for renat safety. 44% of patients had neutropenia
2006

abstract No: 

S123

Full conference title: 

14th International Symposium of Infections in the Immunocompromised Host
    • ISIIH, 14th